These figures should not be interpreted as expected outcomes for compounded products, which have not undergone equivalent clinical trials and have not been reviewed by the FDA for safety, effectiveness, or quality as finished products
An online parallel market for an unlicensed weight-loss drug is being fuelled by TikTok fitness influencers and Telegram sellers, a Guardian investigation can reveal

Key protective strategies include: Pre-treatment ophthalmologic evaluation : Establish baseline retinal status before initiating GLP-1 therapy, particularly in patients with diabetes duration exceeding 10 years or poor prior glycemic control Individualized medication titration : Consider a more gradual dose escalation approach to avoid precipitous drops in blood glucose for patients with advanced diabetic retinopathy, in coordination with ophthalmology care Appropriate monitoring : Discuss with your healthcare provider whether more frequent eye examinations are needed based on your individual risk factors and baseline retinal status Prompt reporting of visual symptoms : Contact your healthcare provider immediately if you experience sudden vision loss, new or dense floaters, flashing lights, a "curtain" over your vision, eye pain with vision changes, or any sudden vision disturbance Patients without pre-existing diabetic retinopathy can generally follow standard eye examination schedules and do not require additional ophthalmologic monitoring solely due to GLP-1 use

The transdermal format is real
ALI, Dehshini, et al
What if I am not losing weight on semaglutide even with fasting